14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $84.38 $96.99 Wednesday, 24th Apr 2024 BPMC stock ended at $92.26. This is 0.0325% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 3.66% from a day low at $90.43 to a day high of $93.74.
90 days $72.25 $100.98
52 weeks $43.89 $100.98

Historical Blueprint Medicines Corporation prices

Date Open High Low Close Volume
Mar 19, 2024 $86.08 $89.45 $84.90 $87.97 1 491 824
Mar 18, 2024 $90.86 $91.67 $86.10 $86.82 996 760
Mar 15, 2024 $87.28 $90.75 $86.58 $90.50 1 120 059
Mar 14, 2024 $90.00 $90.82 $86.36 $87.71 522 631
Mar 13, 2024 $90.43 $92.25 $89.40 $90.60 534 253
Mar 12, 2024 $89.14 $90.44 $87.04 $89.70 475 826
Mar 11, 2024 $92.12 $92.82 $88.69 $89.47 508 387
Mar 08, 2024 $92.18 $94.72 $91.93 $92.30 664 450
Mar 07, 2024 $90.37 $92.74 $89.73 $92.04 992 473
Mar 06, 2024 $89.00 $91.75 $88.92 $90.38 785 257
Mar 05, 2024 $89.41 $90.84 $88.55 $89.67 588 124
Mar 04, 2024 $95.26 $95.69 $90.39 $90.80 623 411
Mar 01, 2024 $93.81 $98.06 $93.73 $95.12 780 008
Feb 29, 2024 $98.82 $98.82 $92.95 $93.52 656 386
Feb 28, 2024 $98.15 $100.98 $95.27 $95.45 883 785
Feb 27, 2024 $95.00 $99.87 $95.00 $99.79 1 499 560
Feb 26, 2024 $89.89 $95.57 $89.37 $95.05 1 258 373
Feb 23, 2024 $86.69 $91.19 $86.62 $89.49 881 190
Feb 22, 2024 $87.00 $88.92 $80.42 $86.00 1 506 681
Feb 21, 2024 $90.07 $92.50 $86.47 $87.26 858 195
Feb 20, 2024 $88.98 $92.83 $88.98 $91.25 974 210
Feb 16, 2024 $90.41 $94.47 $88.82 $90.26 1 090 100
Feb 15, 2024 $77.57 $89.25 $77.57 $87.57 1 628 924
Feb 14, 2024 $72.25 $77.37 $72.25 $76.80 840 439
Feb 13, 2024 $74.15 $75.64 $72.46 $73.17 880 909
Click to get the best stock tips daily for free!

About Blueprint Medicines Corporation

Blueprint Medicines Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of non-advanced SM and other mast cell disorders; and Fisogatinib, an orally avail... BPMC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT